Li‐Sheng Cai

机构：Fujian Medical University, Zhangzhou Municipal Hospital of Fujian Province · ORCID：0000-0002-9762-878X

发表论文 64 篇 · 总被引 1142 次 · h-index 19

代表论文

• Neoadjuvant camrelizumab and apatinib combined with chemotherapy versus chemotherapy alone for locally advanced gastric cancer: a multicenter randomized phase 2 trial (2024 · Nature Communications · 被引 57)
• The safety and efficacy of neoadjuvant immunochemotherapy following laparoscopic gastrectomy for gastric cancer: a multicentre real-world clinical study (2024 · International Journal of Surgery · 被引 26)
• Machine learning identifies the risk of complications after laparoscopic radical gastrectomy for gastric cancer (2024 · World Journal of Gastroenterology · 被引 19)
• Gastric cancer peritoneal metastasis related signature predicts prognosis and sensitivity to immunotherapy in gastric cancer (2023 · Journal of Cellular and Molecular Medicine · 被引 16)
• Efficacy of neoadjuvant chemotherapy combined with prophylactic intraperitoneal hyperthermic chemotherapy for patients diagnosed with clinical T4 gastric cancer who underwent laparoscopic radical gastrectomy: a retrospective cohort study based on propensity score matching (2024 · World Journal of Surgical Oncology · 被引 10)
• The safety, feasibility, and oncological outcomes of laparoscopic completion total gastrectomy for remnant gastric cancer: a prospective study with 3-year follow-up (FUGES-004 study) (2024 · International Journal of Surgery · 被引 9)